Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematologic Malignancies
•
Pediatric Oncology
•
Leukemia
•
AYA
•
Hematology
•
AYA Cancers
How do you preserve fertility in women with newly diagnosed acute leukemia?
Related Questions
What is the benefit of cytoreduction with Hydroxyurea for patients with newly diagnosed chronic phase CML with a WBC count >100 prior to the initiation of a TKI?
Which, if any, young/fit intermediate-risk AML patients would you not offer allogeneic transplant to in MRD- CR1?
For T cell ALL treated in CR (without transplant), how often do you do BM biopsies as part of surveillance, and for how long?
Would you recommend adding a TKI to a pediatric regimen for a AYA B-ALL patient with IKZF1 mutation?
Do you switch from imatinib to another TKI in patients with chronic phase CML who develop renal insufficiency?
Which patients with acute promyelocytic leukemia do you consider maintenance after completing consolidation?
Does the ASAP trial change how we approach relapsed and refractory AML?
Would you use a matched sibling donor with a germline heterozygous BRCA1 mutation for stem cell transplant?
Do you check asparaginase levels for all patients receiving receiving E. coli-derived products, or only in certain clinical situations?
What is your approach to treating a young adult with severe aplastic anemia unresponsive to steroids and TPO-mimetics?
